An indirect role for ASPP1 in limiting p53-dependent p21 expression and cellular senescence

EMBO Journal

Volumn 31, Issue 2, 2012, Pages 471-480

  Vigneron, Arnaud M ^a   Vousden, Karen H ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

ASPP1; LATS2; p21; p53; YAP

Indexed keywords

ASPP1 PROTEIN; DNA; PROTEIN P21; PROTEIN P53; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL AGING; CELL CYCLE ARREST; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA SYNTHESIS; DOWN REGULATION; GENE EXPRESSION; GENE TARGETING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; APOPTOSIS REGULATORY PROTEINS; CELL AGING; CELL LINE, TUMOR; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DACTINOMYCIN; DNA REPLICATION; DNA-BINDING PROTEINS; DOXORUBICIN; GENE EXPRESSION REGULATION; HUMANS; HYDROXYUREA; NUCLEAR PROTEINS; PROTEIN-SERINE-THREONINE KINASES; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84857191608     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/emboj.2011.402     Document Type: Article

References (41)

1. Ahn J, Byeon IJ, Byeon CH, Gronenborn AM (2009) Insight into the structural basis of pro-and antiapoptotic p53 modulation by ASPP proteins. J Biol Chem 284: 13812-13822
2. Ansieau S, Morel AP, Hinkal G, Bastid J, Puisieux A (2010) TWISTing an embryonic transcription factor into an oncoprotein. Oncogene 29: 3173-3184
3. Aylon Y, Ofir-Rosenfeld Y, Yabuta N, Lapi E, Nojima H, Lu X, Oren M (2010) The Lats2 tumor suppressor augments p53-mediated apoptosis by promoting the nuclear proapoptotic function of ASPP1. Genes Dev 24: 2420-2429
4. Aylon Y, Yabuta N, Besserglick H, Buganim Y, Rotter V, Nojima H, Oren M (2009) Silencing of the Lats2 tumor suppressor overrides a p53-dependent oncogenic stress checkpoint and enables mutant H-Ras-driven cell transformation. Oncogene 28: 4469-4479
5. Bergamaschi D, Samuels Y, Jin B, Duraisingham S, Crook T, Lu X (2004) ASPP1 and ASPP2: common activators of p53 family members. Mol Cell Biol 24: 1341-1350 (Pubitemid 38112194)
6. Bergamaschi D, Samuels Y, Sullivan A, Zvelebil M, Breyssens H, Bisso A, Del Sal G, Syed N, Smith P, Gasco M, Crook T, Lu X (2006) iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72-polymorphic p53. Nat Genet 38: 1133-1141 (Pubitemid 44470358)
7. Bergamaschi D, Samuels-Lev Y, O'Neil NJ, Trigiante G, Crook T, Hseih JK, O'Conner DJ, Zhong S, Compargue I, Tomlinson ML, Kuwabara PE, Lu X (2003) iASPP oncoprotein is a key inhibitor of p53 conserved from worms to humans. Nat Genet 33: 162-167 (Pubitemid 36177067)
8. Brady CA, Attardi LD (2010) p53 at a glance. J Cell Sci 123: 2527-2532
9. Chan SW, Lim CJ, Guo K, Ng CP, Lee I, Hunziker W, Zeng Q, Hong W (2008) A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells. Cancer Res 68: 2592-2598 (Pubitemid 351556257)
10. Chang BD, Xuan Y, Broude EV, Zhu H, Schott B, Fang J, Roninson IB (1999) Role of p53 and p21waf1/cip1 in senescence-like terminal proliferation arrest induced in human tumor cells by chemotherapeutic drugs. Oncogene 18: 4808-4818 (Pubitemid 29423564)
11. Chen J, Xie F, Zhang L, Jiang WG (2010) iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway. BMC Cancer 10: 694
12. Cong W, Hirose T, Harita Y, Yamashita A, Mizuno K, Hirano H, Ohno S (2010) ASPP2 regulates epithelial cell polarity through the PAR complex. Curr Biol 20: 1408-1414
13. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA (1999) p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene 18: 2789-2797 (Pubitemid 29250868)
14. Fogal V, Kartasheva NN, Trigiante G, Llanos S, Yap D, Vousden KH, Lu X (2005) ASPP1 and ASPP2 are new transcriptional targets of E2F. Cell Death Differ 12: 369-376 (Pubitemid 40520688)
15. Hershko T, Chaussepied M, Oren M, Ginsberg D (2005) Novel link between E2F and p53: proapoptotic cofactors of p53 are trasncriptionally upregulated by E2F. Cell Death Differ 12: 377-383 (Pubitemid 40520689)
16. Hirashima M, Sano K, Morisada T, Murakami K, Rossant J, Suda T (2008) Lymphatic vessel assembly is impaired in Aspp1-deficient mouse embryos. Dev Biol 316: 149-159
17. Kampa KM, Acoba JD, Chen D, Gay J, Lee H, Beemer K, Padiernos E, Boonmark N, Zhu Z, Fan AC, Bailey AS, Fleming WH, Corless C, Felsher DW, Naumovski L, Lopez CD (2009) Apoptosis-stimulating protein of p53 (ASPP2) heterozygous mice are tumor-prone and have attenuated cellular damage-response thresholds. Proc Natl Acad Sci USA 106: 4390-4395
18. Korotchkina LG, Demidenko ZN, Gudkov AV, Blagosklonny MV (2009) Cellular quiescence caused by the Mdm2 inhibitor nutlin-3A. Cell Cycle (Georgetown, Tex) 8: 3777-3781
19. Kurz DJ, Decary S, Hong Y, Erusalimsky JD (2000) Senescenceassociated (beta)-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci 113 (Part 20): 3613-3622
20. Lei QY, Zhang H, Zhao B, Zha ZY, Bai F, Pei XH, Zhao S, Xiong Y, Guan KL (2008) TAZ promotes cell proliferation and epithelialmesenchymal transition and is inhibited by the hippo pathway. Mol Cell Biol 28: 2426-2436 (Pubitemid 351429986)
21. Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, Ding S, Guan KL (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24: 1106-1118
22. Liu CY, Lv X, Li T, Xu Y, Zhou X, Zhao S, Xiong Y, Lei QY, Guan KL (2011) PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ. J Biol Chem 286: 5558-5566
23. Maddocks OD, Vousden KH (2011) Metabolic regulation by p53. J Mol Med (Berl) 89: 237-245
24. Matallanas D, Romano D, Yee K, Meissl K, Kucerova L, Piazzolla D, Baccarini M, Vass JK, Kolch W, O'Neill E (2007) RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein. Mol Cell 27: 962-975 (Pubitemid 47495894)
25. Mattia M, Gottifredi V, McKinney K, Prives C (2007) p53-Dependent p21 mRNA elongation is impaired when DNA replication is stalled. Mol Cell Biol 27: 1309-1320 (Pubitemid 46239814)
26. Park SW, An CH, Kim SS, Yoo NJ, Lee SH (2010) Mutational analysis of ASPP1 and ASPP2 genes, a p53-related gene, in gastric and cololorectal cancers with microsatellite instability. Gut Liver 4: 292-293
27. Rohaly G, Chemnitz J, Dehde S, Nunez AM, Heukeshoven J, Deppert W, Dornreiter I (2005) A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint. Cell 122: 21-32 (Pubitemid 40977937)
28. Samuels-Lev Y, O'Conner DJ, Bergamaschi D, Trigiante G, Hsieh J-K, Zhong S, Campargue I, Naumovski L, Crook T, Lu X (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Mol Cell 8: 781-794 (Pubitemid 33030212)
29. Sottocornola R, Royer C, Vives V, Tordella L, Zhong S, Wang Y, Ratnayaka I, Shipman M, Cheung A, Gaston-Massuet C, Ferretti P, Molnar Z, Lu X (2010) ASPP2 binds Par-3 and controls the polarity and proliferation of neural progenitors during CNS development. Dev Cell 19: 126-137
30. Strano S, Monti O, Pediconi N, Baccarini A, Fontemaggi G, Lapi E, Mantovani F, Damalas A, Citro G, Sacchi A, Del Sal G, Levrero M, Blandino G (2005) The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol Cell 18: 447-459 (Pubitemid 40704759)
31. Sullivan A, Lu X (2007) ASPP: a new family of oncogenes and tumour suppressor genes. Br J Cancer 96: 196-200 (Pubitemid 46160620)
32. Tschop K, Conery AR, Litovchick L, Decaprio JA, Settleman J, Harlow E, Dyson N (2011) A kinase shRNA screen links LATS2 and the pRB tumor suppressor. Genes Dev 25: 814-830
33. Vigneron AM, Ludwig RL, Vousden KH (2010) Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP. Genes Dev 24: 2430-2439
34. Vives V, Su J, Zhong S, Ratnayaka I, Slee E, Goldin R, Lu X (2006) ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes Dev 20: 1262-1267 (Pubitemid 43727587)
35. Vogelstein B, Lane D, Levine AJ (2000) Surfing the p53 network. Nature 408: 307-310
36. Vousden KH, Prives C (2009) Blinded by the light: the growing complexity of p53. Cell 137: 413-431
37. Wang XD, Lapi E, Sullivan A, Ratnayaka I, Goldin R, Hay R, Lu X (2011) SUMO-modified nuclear cyclin D1 bypasses Ras-induced senescence. Cell Death Differ 18: 304-314
38. Zhang J, Smolen GA, Haber DA (2008) Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway. Cancer Res 68: 2789-2794 (Pubitemid 351556277)
39. Zhao B, Li L, Lei Q, Guan KL (2010a) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev 24: 862-874
40. Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL (2008) TEAD mediates YAPdependent gene induction and growth control. Genes Dev 22: 1962-1971 (Pubitemid 352008643)
41. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L, Tong X, Lu X, Wu M, Guo Y (2010b) Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region-containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 51: 142-153